Literature DB >> 10397619

Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.

M J Portela1, R Moreira, E Valente, L Constantino, J Iley, J Pinto, R Rosa, P Cravo, V E do Rosário.   

Abstract

PURPOSE: Dipeptide derivatives of primaquine (PQ) with reduced oxidative deamination to the inactive metabolite carboxyprimaquine were synthesized and evaluated as a novel class of transmission-blocking antimalarials. METHODS; Antimalarial activity was studied using a model consisting of mefloquine-resistant Plasmodium berghei ANKA 25R/10, Balb C mice, and Anopheles stephensi mosquitoes. Metabolic studies were performed with rat liver homogenates, and the incubates were analyzed by HPLC.
RESULTS: All dipeptide derivatives and glycyl-PQ completely inhibited the appearance of oocysts in the midguts of the mosquitoes at 15 mg/ kg, while N-acetylprimaquine was not active at this dose. However, none of the title compounds were able to block oocyst production at 3.75 mg/kg, in contrast with primaquine. Exception for sarc-gly-PQ, all remaining compounds prevented sporozoite formation in the salivary glands of mosquitoes at a dose of 3.75 mg/kg. Simultaneous hydrolysis to primaquine and gly-PQ ocurred with the following order of Vmax/Km: for primaquine formation. L-ala-gly-PQ > L-phe-gly-PQ > gly-gly-PQ; and for gly-PQ formation, L-phe-gly-PQ > L-ala-gly-PQ > gly-gly-PQ. In contrast, primaquine was not released from D-phe-gly-PQ, sarc-gly-PQ, and N-acetylprimaquine. Neither carboxyprimaquine nor 8-amino-6-methoxyquinoline were detected in any of the incubation mixtures.
CONCLUSIONS: The title compounds prevent the development of the sporogonic cycle of Plasmodium berghei. Gametocytocidal activity is independent of the rate and pathway of primaquine formation. Acylation of the aliphatic side-chain effectively prevents the formation of carboxyprimaquine, but the presence of a terminal amino group appears to be essential for the gametocytocidal activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397619     DOI: 10.1023/a:1018922425551

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Effect of mefloquine and artemisinin on the sporogonic cycle of Plasmodium berghei ANKA in Anopheles stephensi mosquitoes.

Authors:  R E Coleman; J A Vaughan; D O Hayes; M R Hollingdale; V E Do Rosario
Journal:  Acta Leiden       Date:  1988

2.  Population dynamics of Plasmodium falciparum sporogony in laboratory-infected Anopheles gambiae.

Authors:  J A Vaughan; B H Noden; J C Beier
Journal:  J Parasitol       Date:  1992-08       Impact factor: 1.276

3.  The microsomal dealkylation of N,N-dialkylbenzamides.

Authors:  J Iley; L Constantino
Journal:  Biochem Pharmacol       Date:  1994-01-20       Impact factor: 5.858

4.  Prevention of sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes by transmission-blocking antimalarials.

Authors:  R E Coleman; A K Nath; I Schneider; G H Song; T A Klein; W K Milhous
Journal:  Am J Trop Med Hyg       Date:  1994-05       Impact factor: 2.345

5.  Effects of an NADPH-generating system on primaquine degradation by hamster liver fractions.

Authors:  S Abu-El-Haj; R Allahyari; E Chavez; I M Fraser; A Strother
Journal:  Xenobiotica       Date:  1988-10       Impact factor: 1.908

6.  Development of new derivatives of primaquine by association with lysosomotropic carriers.

Authors:  A U Trouet; P Pirson; R Steiger; M Masquelier; R Baurain; J Gillet
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

7.  Excretion, distribution, and metabolism of primaquine in rats.

Authors:  A M Clark; J K Baker; J D McChesney
Journal:  J Pharm Sci       Date:  1984-04       Impact factor: 3.534

8.  Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR Mice and Anopheles stephensi mosquitoes.

Authors:  R E Coleman; A M Clavin; W K Milhous
Journal:  Am J Trop Med Hyg       Date:  1992-02       Impact factor: 2.345

9.  Antimalarial activity and inhibition of monoamine oxidases A and B by exo-erythrocytic antimalarials. Optical isomers of primaquine, N-acylated congeners, primaquine metabolites and 5-phenoxy-substituted analogues.

Authors:  A Brossi; P Millet; I Landau; M E Bembenek; C W Abell
Journal:  FEBS Lett       Date:  1987-04-20       Impact factor: 4.124

10.  Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations.

Authors:  J K Baker; R H Yarber; N P Nanayakkara; J D McChesney; F Homo; I Landau
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

View more
  7 in total

Review 1.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

2.  Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantum.

Authors:  Sílvia Vale-Costa; Nuno Vale; Joana Matos; Ana Tomás; Rui Moreira; Paula Gomes; Maria Salomé Gomes
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

3.  Imidazoquines as antimalarial and antipneumocystis agents.

Authors:  Nuno Vale; Miguel Prudêncio; Catarina A Marques; Margaret S Collins; Jiri Gut; Fátima Nogueira; Joana Matos; Philip J Rosenthal; Melanie T Cushion; Virgílio E do Rosário; Maria M Mota; Rui Moreira; Paula Gomes
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

4.  Evaluation of antimalarial activity and toxicity of a new primaquine prodrug.

Authors:  Marcelo Gomes Davanço; Anna Caroline Campos Aguiar; Leandro Alves Dos Santos; Elias Carvalho Padilha; Michel Leandro Campos; Cleverton Roberto de Andrade; Luiz Marcos da Fonseca; Jean Leandro Dos Santos; Chung Man Chin; Antoniana Ursine Krettli; Rosangela Gonçalves Peccinini
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

5.  An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.

Authors:  Rithea Leang; Naw Htee Khu; Mavuto Mukaka; Mark Debackere; Rupam Tripura; Soy Ty Kheang; Say Chy; Neeraj Kak; Philippe Buchy; Arnaud Tarantola; Didier Menard; Arantxa Roca-Felterer; Rick M Fairhurst; Sim Kheng; Sinoun Muth; Song Ngak; Arjen M Dondorp; Nicholas J White; Walter Robert John Taylor
Journal:  BMC Med       Date:  2016-10-27       Impact factor: 8.775

Review 6.  Prodrugs for the treatment of neglected diseases.

Authors:  Man Chin Chung; Elizabeth Igne Ferreira; Jean Leandro Santos; Jeanine Giarolla; Daniela Gonçales Rando; Adélia Emília Almeida; Priscila Longhin Bosquesi; Renato Farina Menegon; Lorena Blau
Journal:  Molecules       Date:  2007-03-19       Impact factor: 4.411

Review 7.  Primaquine derivatives: Modifications of the terminal amino group.

Authors:  Branka Zorc; Ivana Perković; Kristina Pavić; Zrinka Rajić; Maja Beus
Journal:  Eur J Med Chem       Date:  2019-08-23       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.